If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What information does Lilly have for a patient who accidentally injects tirzepatide in the wrong location?
Tirzepatide should be injected subcutaneously in the abdomen, thigh, or upper arm. Eli Lilly and Company has no clinical information for injecting the medication in other locations.
See important safety information, including boxed warning, in the attached prescribing information.
Enclosed Prescribing Information
Date of Last Review: May 19, 2022